Can India’s pharmaceutical industry achieve self-reliance in APIs? by Chetan Shah, COO, Senores Pharmaceuticals
Through strong industry cooperation, significant investment, and smart policy backing, API manufacturing may become self-reliant
Through strong industry cooperation, significant investment, and smart policy backing, API manufacturing may become self-reliant
This expanded partnership helps Evonik to streamline its distribution model in Asia Pacific
VITADEETM Green is a 100% plant-based Vitamin D3 suitable for food & nutraceuticals
Q3 FY25 revenue up 24% to Rs 3,230 crore
Modernization and supply chain diversity drive new growth
Revenue from Operations during Q2 FY25 was Rs. 3,077 crore as compared to Rs. 2,708 crore in Q2 FY24.
Acquisition in line with Mankind’s stated objective to expand its presence in high entry barrier complex portfolios and high potential OTX brands
India's healthcare sector anticipates telemedicine reaching US$ 5.4 billion by 2025, with AI growing at 45% by 2024 and Healthtech jobs increasing 15-20%
Combination will create a Canadian Health Champion spanning generic, biosimilar and branded pharmaceuticals
The plant will drive pharmaceutical innovation in the Northeastern India
Subscribe To Our Newsletter & Stay Updated